Similar articles

• Application of pharmacoeconomics to formulary decision making in managed care organizations.

  Suh DC, Okpara IR, Agnese WB, Toscani M. Suh DC, et al. Am J Manag Care. 2002 Feb;8(2):161-9. Am J Manag Care. 2002. PMID: 11858228 Review.
• Pharmacoeconomics: a managed care perspective.

  Clouse JC. Clouse JC. Top Hosp Pharm Manage. 1994 Jan;13(4):54-9. Top Hosp Pharm Manage. 1994. PMID: 10130684
• The role of pharmacoeconomic modeling in depression management by a health plan.

  Watkins JB. Watkins JB. Manag Care Interface. 2003;Suppl B:22-6. Manag Care Interface. 2003. PMID: 12647610 No abstract available.
• Reinventing the PBM (pharmacy benefit manager).

  Marcille JA, Wynn P. Marcille JA, et al. Manag Care. 1997 Apr;6(4):64-6, 75-8. Manag Care. 1997. PMID: 10167003 No abstract available.
• The arrival of economic evidence in managed care formulary decisions: the unsolicited request process.

  Neumann PJ. Neumann PJ. Med Care. 2005 Jul;43(7 Suppl):27-32. doi: 10.1097/01.mlr.0000170005.09751.b4. Med Care. 2005. PMID: 16056006 Review.